Versant Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$456K Sell
1,169
-489
-29% -$207K 0.04% 321
2026
Q1
$785K Buy
1,658
+301
+22% +$152K 0.08% 158
2025
Q4
$634K Buy
1,357
+109
+9% +$50.6K 0.08% 165
2025
Q3
$532K Buy
1,248
+23
+2% +$8.91K 0.07% 190
2025
Q2
$469K Buy
1,225
+637
+108% +$230K 0.07% 187
2025
Q1
$203K Buy
588
+185
+46% +$59.5K 0.03% 419
2024
Q4
$121K Buy
403
+71
+21% +$24.8K 0.03% 260
2024
Q3
$135K Buy
332
+83
+33% +$30.4K 0.03% 193
2024
Q2
$80K Buy
249
+176
+241% +$57.2K 0.02% 250
2024
Q1
$24.3K Hold
73
0.01% 447
2023
Q4
$19.8K Buy
73
+3
+4% +$741 0.01% 502
2023
Q3
$17.2K Sell
70
-1
-1% -$274 0.01% 530
2023
Q2
$21.5K Buy
71
+6
+9% +$1.67K 0.01% 484
2023
Q1
$17.1K Buy
65
+52
+400% +$13.2K 0.01% 538
2022
Q4
$3.12K Hold
13
﹤0.01% 1024
2022
Q3
$2K Hold
13
﹤0.01% 1077
2022
Q2
$2K Hold
13
﹤0.01% 1097
2022
Q1
$3K Hold
13
﹤0.01% 1031
2021
Q4
$3K Hold
13
﹤0.01% 1032
2021
Q3
$3K Hold
13
﹤0.01% 1040
2021
Q2
$3K Hold
13
﹤0.01% 1043
2021
Q1
$2K Hold
13
﹤0.01% 1236
2020
Q4
$2K Hold
13
﹤0.01% 1120
2020
Q3
$1K Hold
13
﹤0.01% 1176
2020
Q2
$1K Hold
13
﹤0.01% 1169
2020
Q1
$1K Sell
13
-6
-32% -$777 ﹤0.01% 1145
2019
Q4
$2K Sell
19
-24
-56% -$3.22K ﹤0.01% 1138
2019
Q3
$5K Hold
43
﹤0.01% 947
2019
Q2
$5K Sell
43
-14
-25% -$1.77K ﹤0.01% 958
2019
Q1
$7K Hold
57
﹤0.01% 1014
2018
Q4
$7K Hold
57
﹤0.01% 925
2018
Q3
$7K Hold
57
﹤0.01% 987
2018
Q2
$5K Hold
57
﹤0.01% 1083
2018
Q1
$5K Sell
57
-13
-19% -$1.26K ﹤0.01% 1063
2017
Q4
$6K Sell
70
-11
-14% -$884 ﹤0.01% 1066
2017
Q3
$6K Sell
81
-24
-23% -$1.93K ﹤0.01% 1004
2017
Q2
$9K Buy
105
+11
+12% +$931 0.01% 894
2017
Q1
$8K Sell
94
-5
-5% -$417 ﹤0.01% 911
2016
Q4
$7K Sell
99
-53
-35% -$3.97K ﹤0.01% 933
2016
Q3
$11K Sell
152
-7
-4% -$536 0.01% 776
2016
Q2
$12K Buy
159
+5
+3% +$395 0.01% 716
2016
Q1
$12K Buy
154
+60
+64% +$4.19K 0.01% 698
2015
Q4
$6K Buy
+94
New +$6.56K ﹤0.01% 885

Other funds holding HCA

Versant Capital Management's HCA Position: Q2 2026 in Review

Versant Capital Management reduced its HCA Healthcare (HCA) stake by 29% in Q2 2026, selling an estimated $207K and leaving 1,169 shares worth $456K. The position accounts for 0.04% of the portfolio, ranked #321.

Versant Capital Management first reported a position in HCA in Q4 2015 and has held it in 43 quarters since. The position peaked at $785K in Q1 2026. 216 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Versant Capital Management held 1,169 shares of HCA Healthcare worth $456K as of Q2 2026.
  • Versant Capital Management sold 489 HCA Healthcare shares in Q2 2026, an estimated $207K.
  • HCA Healthcare made up 0.04% of Versant Capital Management's portfolio in Q2 2026, its #321 holding.
  • Versant Capital Management first reported a position in HCA Healthcare in Q4 2015 and has held it in 43 quarters since.
  • Versant Capital Management's HCA Healthcare position peaked at $785K in Q1 2026.
  • 216 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.